Impact of Surgical Management for Relapse After Conversion Hepatectomy for Initially Unresectable Colorectal Liver Metastasis: A Retrospective Cohort Study

Siegel, 2020, Colorectal cancer statistics, 2020, CA Cancer J Clin, 70, 145, 10.3322/caac.21601 Van Cutsem, 2010, Advanced colorectal cancer: ESMO Clinical Practice Guidelines for treatment, Ann Oncol, 21, v93, 10.1093/annonc/mdq222 Hadden, 2016, Resection of colorectal liver metastases and extra-hepatic disease: a systematic review and proportional meta-analysis of survival outcomes, HPB (Oxford), 18, 209, 10.1016/j.hpb.2015.12.004 Vibert, 2005, Strategies to treat primary unresectable colorectal liver metastases, Semin Oncol, 32, 33, 10.1053/j.seminoncol.2005.07.015 Nordlinger, 2007, Does chemotherapy prior to liver resection increase the potential for cure in patients with metastatic colorectal cancer? A report from the European Colorectal Metastases Treatment Group, Eur J Cancer, 43, 2037, 10.1016/j.ejca.2007.07.017 Adam, 2004, Hepatic colorectal metastases: methods of improving resectability, Surg Clin North Am, 84, 659, 10.1016/j.suc.2003.12.005 Fusai, 2003, Management of colorectal liver metastases, Colorectal Dis, 5, 2, 10.1046/j.1463-1318.2003.00410.x Chan, 2020, Perioperative Chemotherapy for Liver Metastasis of Colorectal Cancer, Cancers (Basel), 12, 10.3390/cancers12123535 Ye, 2013, Randomized controlled trial of cetuximab plus chemotherapy for patients with KRAS wild-type unresectable colorectal liver-limited metastases, J Clin Oncol, 31, 1931, 10.1200/JCO.2012.44.8308 Tang, 2020, Bevacizumab Plus mFOLFOX6 Versus mFOLFOX6 Alone as First-Line Treatment for RAS Mutant Unresectable Colorectal Liver-Limited Metastases: The BECOME Randomized Controlled Trial, J Clin Oncol, 38, 3175, 10.1200/JCO.20.00174 Passot, 2016, Recent Advances in Chemotherapy and Surgery for Colorectal Liver Metastases, Liver Cancer, 6, 72, 10.1159/000449349 Bolhuis, 2020, Conversion strategies with chemotherapy plus targeted agents for colorectal cancer liver-only metastases: A systematic review, Eur J Cancer, 141, 225, 10.1016/j.ejca.2020.09.037 Adam, 2009, Patients with initially unresectable colorectal liver metastases: is there a possibility of cure?, J Clin Oncol, 27, 1829, 10.1200/JCO.2008.19.9273 Cauchy, 2012, Reappraisal of the risks and benefits of major liver resection in patients with initially unresectable colorectal liver metastases, Ann Surg, 256, 746, 10.1097/SLA.0b013e3182738204 Homayounfar, 2014, Discrepancies between medical oncologists and surgeons in assessment of resectability and indication for chemotherapy in patients with colorectal liver metastases, Br J Surg, 101, 550, 10.1002/bjs.9436 Krell, 2015, Surgical Referral for Colorectal Liver Metastases: A Population-Based Survey, Ann Surg Oncol, 22, 2179, 10.1245/s10434-014-4318-x Drefs, 2021, Chances, challenges and outcomes of patients with complex bilobar colorectal liver metastases approached by a combined multimodal therapy with liver resection and local ablative therapy, J Surg Oncol, 123, 1578, 10.1002/jso.26443 Krall, 2018, The systemic response to surgery triggers the outgrowth of distant immune-controlled tumors in mouse models of dormancy, Sci Transl Med, 10, 10.1126/scitranslmed.aan3464 Chen, 2019, Surgical stress and cancer progression: the twisted tango, Mol Cancer, 18, 132, 10.1186/s12943-019-1058-3 Dorcaratto, 2019, Impact of Postoperative Complications on Survival and Recurrence After Resection of Colorectal Liver Metastases: Systematic Review and Meta-analysis, Ann Surg, 270, 1018, 10.1097/SLA.0000000000003254 Mansmann, 2013, Deepness of response: A quantitative analysis of its impact on post-progression survival time after first-line treatment in patients with mCRC, Journal of Clinical Oncology, 31, 427, 10.1200/jco.2013.31.4_suppl.427 Clavien, 2009, The Clavien-Dindo classification of surgical complications: five-year experience, Ann Surg, 250, 187, 10.1097/SLA.0b013e3181b13ca2 Jian, 2019, Predictive And Prognostic Value Of Hepatic Steatosis In Conversion Therapy For Colorectal Liver-limited Metastases: A Propensity Score Matching Analysis, Cancer Manag Res, 11, 8315, 10.2147/CMAR.S210185 Feng, 2019, Tumor-associated Macrophages as Prognostic and Predictive Biomarkers for Postoperative Adjuvant Chemotherapy in Patients with Stage II Colon Cancer, Clin Cancer Res, 25, 3896, 10.1158/1078-0432.CCR-18-2076 Tomasello, 2017, FOLFOXIRI Plus Bevacizumab as Conversion Therapy for Patients With Initially Unresectable Metastatic Colorectal Cancer: A Systematic Review and Pooled Analysis, JAMA Oncol, 3, 10.1001/jamaoncol.2017.0278 Folprecht, 2014, Survival of patients with initially unresectable colorectal liver metastases treated with FOLFOX/cetuximab or FOLFIRI/cetuximab in a multidisciplinary concept (CELIM study), Ann Oncol, 25, 1018, 10.1093/annonc/mdu088 Adam, 2004, Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival, Ann Surg, 240, 644, 10.1097/01.sla.0000141198.92114.f6 Cojoc, 2015, A role for cancer stem cells in therapy resistance: cellular and molecular mechanisms, Semin Cancer Biol, 31, 16, 10.1016/j.semcancer.2014.06.004 Biller, 2021, Diagnosis and Treatment of Metastatic Colorectal Cancer: A Review, JAMA, 325, 669, 10.1001/jama.2021.0106 Ren, 2020, Shanghai international consensus on diagnosis and comprehensive treatment of colorectal liver metastases (version 2019), Eur J Surg Oncol, 46, 955, 10.1016/j.ejso.2020.02.019 Van Cutsem, 2016, ESMO consensus guidelines for the management of patients with metastatic colorectal cancer, Ann Oncol, 27, 1386, 10.1093/annonc/mdw235 Ruers, 2012, Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004), Ann Oncol, 23, 2619, 10.1093/annonc/mds053 Ruers, 2017, Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial, J Natl Cancer Inst, 109, 10.1093/jnci/djx015 Chen, 2020, Comprehensive Evaluation of Relapse Risk (CERR) Score for Colorectal Liver Metastases: Development and Validation, Oncologist, 25, e1031, 10.1634/theoncologist.2019-0797 Lee, 2020, Carbohydrate antigen 19-9 - tumor marker: Past, present, and future, World J Gastrointest Surg, 12, 468, 10.4240/wjgs.v12.i12.468 Vigano, 2022, Very Early Recurrence After Liver Resection for Colorectal Metastases: Incidence, Risk Factors, and Prognostic Impact, J Gastrointest Surg, 26, 570, 10.1007/s11605-021-05123-w